Exchange: NASDAQ·Updated 02:52 PM EDT
AVIR logo

AVIR Atea Pharmaceuticals Inc

$5.86
$0.04
(0.69%)
Today
Reported EarningsAug 12
Mkt Cap$466.79M
Vol105,450.00

About AVIR

Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.
29

Bearish Sentiment

How do you feel about AVIR?

Advertisement|Remove ads.